Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Payables (2016 - 2025)

Creative Medical Technology Holdings has reported Payables over the past 15 years, most recently at $270686.0 for Q4 2025.

  • Quarterly Payables fell 1.04% to $270686.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $270686.0 through Dec 2025, down 1.04% year-over-year, with the annual reading at $270686.0 for FY2025, 1.04% down from the prior year.
  • Payables was $270686.0 for Q4 2025 at Creative Medical Technology Holdings, up from $247159.0 in the prior quarter.
  • Over five years, Payables peaked at $3.3 million in Q4 2022 and troughed at $247159.0 in Q3 2025.
  • The 5-year median for Payables is $331762.0 (2022), against an average of $649840.2.
  • Biggest five-year swings in Payables: surged 328.89% in 2022 and later crashed 90.29% in 2023.
  • Tracing CELZ's Payables over 5 years: stood at $761862.0 in 2021, then surged by 328.89% to $3.3 million in 2022, then crashed by 90.29% to $317280.0 in 2023, then dropped by 13.79% to $273530.0 in 2024, then dropped by 1.04% to $270686.0 in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $270686.0, $247159.0, and $263450.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.